<i>Extraocular Muscle Susceptibility to Myasthenia Gravis</i>

Annals of the New York Academy of Sciences - Tập 1132 Số 1 - Trang 220-224 - 2008
Jindřich Šoltýs1, Bendi Gong2, Henry J. Kaminski2, Yuefang Zhou2, Linda L. Kusner2
1Department of Neurology & Psychiatry, Saint Louis University, 1438 South Grand Avenue, St. Louis, MO 63104, USA.
2Department of Neurology and Psychiatry, Saint Louis University, St. Louis, Missouri, USA.

Tóm tắt

Extraocular muscle (EOM) is susceptible to neuromuscular junction disorders, in particular, myasthenia gravis (MG). While EOM physiological characteristics and the ocular motor system requirements contribute to the propensity of ocular motor deficits observed among patients with MG, the authors propose that EOM have immunological features that place the muscles at risk for immune attack. Genomic profiling studies have demonstrated that genes associated with the immune response are differentially expressed in EOM, with particular differences in both classical and alternative complement‐mediated immune response pathways. Intrinsic complement regulators are expressed at lower levels at rodent EOM neuromuscular junctions, which would put them at risk for the complement‐mediated injury that occurs in MG. In fact, systemic C inhibition in experimental autoimmune MG (EAMG) induced by administration of acetylcholine receptor (AChR) antibodies or immunization with AChR will eliminate complement deposition at junctions of other skeletal muscle, but not EOM. Also, EOM junctions have greater injury in active and passive EAMG by several measures, suggesting that the lack of complement inhibition puts the EOM at risk. Among ocular myasthenia patients, serum AChR antibody levels are low, which would support the concept that EOM junctions are more susceptible to antibody injury than are other junctions. These observations suggest that complement inhibitory therapies may prove to be particularly effective in treatment of ocular myasthenia.

Từ khóa


Tài liệu tham khảo

Engel A., 1999, The Myasthenic Syndromes

10.1007/978-1-59259-341-5

10.1111/j.1365-2249.2005.02824.x

10.1210/er.2002-0020

10.1196/annals.1254.043

10.1016/j.expneurol.2004.06.005

Kaminski H., 2008, Advances in Understanding Mechanisms and Treatment of Infantile Forms of Nystagmus

10.1097/01.nrl.0000240856.03505.b5

10.1007/0-387-34134-X_6

10.1056/NEJM200104053441406

10.1172/JCI29894

Janeway C., 2001, Immunobiology. The Immune System in Health and Disease, 35

10.1016/S1567-5769(00)00043-6

10.1084/jem.160.5.1558

10.1084/jem.163.4.837

10.1084/jem.170.3.637

10.1172/JCI114172

Harada R., 1990, Purification of 1F5 antigen that prevents complement attack on homologous cell membranes, J. Immunol., 144, 1823, 10.4049/jimmunol.144.5.1823

10.1021/bi00370a003

10.1084/jem.163.5.1150

10.1046/j.1365-2567.2001.01287.x

10.1586/1744666X.4.1.43

10.3181/00379727-105-26051

10.1097/00005072-197803000-00008

10.1097/00005072-198003000-00005

10.1212/WNL.43.6.1167

10.1084/jem.147.4.973

10.4049/jimmunol.142.8.2654

10.1016/S0165-5728(96)00144-0

10.4049/jimmunol.179.12.8562

10.1111/j.1365-2249.2006.03205.x

10.4049/jimmunol.140.8.2589

10.4049/jimmunol.171.7.3847

10.1016/j.expneurol.2006.06.003

10.1172/JCI0216086

10.1016/0165-5728(87)90075-0

10.1073/pnas.80.13.4089

10.1056/NEJM197805182982004

10.1002/mus.880020304

10.1016/j.jneuroim.2006.07.016

10.1073/pnas.211257298

Cheng G., 2002, Transcriptional profile of rat extraocular muscle by serial analysis of gene expression, Invest. Ophthalmol. Vis. Sci., 43, 1048

10.1152/physiolgenomics.00115.2001

10.1152/physiolgenomics.00158.2004

10.1002/(SICI)1097-4598(199701)20:1<92::AID-MUS12>3.0.CO;2-3

10.1111/j.1749-6632.1987.tb51321.x

10.1016/0022-510X(83)90095-3

10.1212/WNL.48.Suppl_5.23S

10.1056/NEJMoa061648

Thông tin
Thông tin xuất bản

Annals of the New York Academy of Sciences

Tập 1132 Số 1

220-224

Thông tin tác giả